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Introduction
Centrosome amplification, the presence of extra centrosomes, 
is found in many preinvasive carcinomas and most late-stage 
human solid tumor cells (Lingle and Salisbury, 2000; Pihan 
et al., 2003; Sagona and Stenmark, 2010). Supernumerary cen-
trosomes generate chromosomal instability by increasing the 
incidence of unequal chromosome distribution on multipolar 
spindles (Brinkley, 2001; Nigg, 2002) or by generating mero-
telically attached chromosomes that are prone to missegregate 
(Cimini et al., 2001) even if the spindle becomes bipolar be-
cause of centrosome bundling (Ganem et al., 2009; Silkworth 
et al., 2009). Consequent whole-chromosome losses/gains lead 
to genetic imbalances that may promote unregulated growth, 
loss of heterozygosity for tumor suppressor genes, and re-
sistance to chemotherapeutic agents (Lengauer et al., 1997; 
Orr-Weaver and Weinberg 1998; Pihan et al., 1998; Nigg, 2002, 
2006). Chromosome instability is thought to be a major driver 
of multistep carcinogenesis (Pihan et al., 2001; D’Assoro et al., 
2002; Goepfert et al., 2002; Krämer et al., 2002; Lingle et al., 
2002; Weaver et al., 2007; Basto et al., 2008; Chandhok and 
Pellman, 2009).
How an incidence of centrosome amplification is estab-
lished and maintained in tumor cell populations is not well 
understood. Possibilities include centriole reduplication (Balczon 
et al., 1995), centriole overduplication (Kleylein-Sohn et al., 
2007; Duensing et al., 2009), de novo centriole assembly, and 
cleavage failure (and equivalent cell–cell fusion) particularly if 
they were ongoing events (Brinkley, 2001; Krämer et al., 2002; 
Meraldi et al., 2002; Nigg, 2002, 2006; Storchova and Pellman, 
2004; Sagona and Stenmark, 2010). Overexpression of SAK/
PLK4 or expression of the high risk papillomavirus protein E7 
causes centriole overduplication and is implicated in tumor de-
velopment (Ko et al., 2005; Duensing et al., 2009). Centrosome 
amplification from de novo centriole assembly would re-
quire cooperating defects because this phenomenon has been 
observed only after the resident centrioles have been removed 
(La Terra et al., 2005; Uetake et al., 2007).
Cleavage failure is another direct route to the establish-
ment of an incidence of centrosome amplification in cell popu-
lations. For untransformed cells, it might be the only avenue to 
We tested whether cleavage failure as a tran-sient event establishes an incidence of centro-some amplification in cell populations. Five 
rounds of 30% cytochalasin-induced cleavage failure in 
untransformed human cell cultures did not establish centro-
some amplification in the short or long terms. The prog-
eny of binucleate cells progressively dropped out of the 
cell cycle and expressed p53/p21, and none divided 
a fourth time. We also tested whether cleavage failure 
established centrosome amplification in transformed cell 
populations. Tetraploid HCT116 p53/ cells eventually 
all failed cleavage repeatedly and ceased proliferating. 
HeLa cells all died or arrested within four cell cycles. 
Chinese hamster ovary cells proliferated after cleavage 
failure, but five rounds of induced cleavage failure pro-
duced a modest increase in the incidence of centrosome 
amplification in the short term, which did not rise with 
more cycles of cleavage failure. This incidence dropped to 
close to control values in the long term despite a 2–6% 
rate of spontaneous cleavage failure in the progeny of 
tetraploid cells.
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scored because time-lapse recordings (described in the second 
following paragraph) revealed that these were cells that arrested 
in first interphase. Data from two experiments with closely simi-
lar results are pooled for presentation.
Control cultures exhibited no centrosome amplification 
(n = 2,125). For all rounds of cleavage failure and subsequent 
passages collectively, we found only six cells of 9,552 scored that 
contained five to six centrioles (Fig. 1 A). For reasons outlined 
in the following paragraph, these cells were probably not prolif-
erative. Importantly, there was no correlation between rounds of 
cleavage failure and the incidence of centrosome amplification. 
Thus, repeated cleavage failure is not sufficient to establish 
an incidence of centrosome amplification in untransformed 
cell populations.
To gain insight into this, individual binucleate cells and 
control cells in the same preparations were continuously fol-
lowed for 100–168 h by video microscopy starting shortly after 
cytochalasin treatment. 48 control cells and their progeny prop-
agated through six mitoses (Fig. 1 B, green bars) with a mean 
cell cycle duration of 17.3 h (n = 277) with no slowing of the 
cell cycle at later times in the film runs. For 120 binucleate cells, 
we found that progressively fewer and fewer of the progeny 
entered mitosis at each cell cycle (Fig. 1 B, yellow bars), 
and none divided a fourth time. For as long as the tetraploid 
cells propagated, their cell cycle duration was on average 18.5 h 
(n = 117). The gradual interphase arrest of the progeny of bi-
nucleate cells was not simply caused by catastrophic chromo-
some loss through multipolar divisions because 52 of the 
starting binucleate cells showed strictly bipolar lineages yield-
ing 87 progeny remaining in the microscope fields, and none 
divided a fourth time.
These results are not particular to RPE1 cells. We fol-
lowed 14 control and 44 same-preparation binucleate primary 
human fibroblasts for 100 h. The control cells proliferated 
through six mitoses at a 90–100% rate before the film re-
cordings were terminated because of confluency (Fig. S2, green 
bars). The progeny of the binucleate cells, however, progres-
sively dropped out of the cell cycle, and none entered a fourth 
mitosis even though 79% of the mitoses were bipolar (Fig. S2, 
yellow bars; and Table S1).
We note that 40–50% of the RPE1 cells and primary fibro-
blasts arrested as binucleates after cytochalasin-induced cleav-
age failure. Given that G1 progression in untransformed cells is 
extremely sensitive to the presence of cytochalasin (Lohez 
et al., 2003; Uetake and Sluder, 2004), we blocked cleavage in 
RPE1 cells with the myosin II inhibitor ()-blebbistatin and 
followed binucleate cells and their same-preparation controls 
for 70–118 h. Nine control cells propagated through up to six 
mitoses before the film runs were terminated. For cells that failed 
cleavage, 28 of 30 progressed through the first postcleavage-
failure mitosis. After that, their progeny progressively dropped 
out of the cell cycle with none dividing a fourth time (Fig. 1 C). 
Thus, the immediate postcleavage-failure arrest we observed 
for some tetraploid cells appears to be largely caused by residual 
cytochalasin, not tetraploidy. Also, the progressive withdrawal of 
doubled cells from the cell cycle is not specific to cytochalasin-
induced cleavage failure.
centrosome amplification because these cells do not show centri-
ole reduplication/overduplication or de novo centriole assem-
bly. Failure to divide immediately doubles centrosome number, 
and centrosome bundling at mitosis could maintain elevated 
centrosome content by allowing cells to undergo bipolar divi-
sions (Borel et al., 2002; Sluder and Nordberg, 2004; Uetake 
and Sluder, 2004; Ganem et al., 2009). Importantly, doubling of 
the genome after cleavage failure increases the probability that 
some daughters of multipolar divisions will have enough chro-
mosomes to remain viable. The importance of cleavage failure 
in the evolution of cellular transformation in vivo is supported 
by observations that tetraploidization often precedes aneuploidy 
in solid tumors (Shackney et al., 1989; Levine et al., 1991; 
Galipeau et al., 1996; Reid et al., 1996; Ganem et al., 2007). 
Also, the injection of tetraploid p53/ mouse embryo fibro-
blasts into nude mice produces tumors, whereas the injection of 
diploid cells does not (Fujiwara et al., 2005).
Nevertheless, the ability of cleavage failure as a transient 
event to establish centrosome amplification in proliferating cell 
populations has not been directly examined. We tested whether 
repeated rounds of cleavage failure can establish centrosome 
amplification in populations of untransformed human cells. We 
also tested whether cooperating defects, such as a compromised 
p53 pathway, can enable cleavage failure to establish centro-
some amplification in populations of transformed cells.
Results and discussion
Untransformed cells
We used human telomerase reverse transcriptase (hTERT)–
immortalized RPE1 cells stably expressing low levels of cen-
trin1/GFP to tag the centrioles. The centriole number per cell 
was determined by the number of bright focal GFP spots and/or 
immunostaining with a -tubulin monoclonal antibody, show-
ing a consistent 1:1 colocalization between GFP spots and 
-tubulin–reactive spots (Fig. S1 A). Time-lapse recordings 
revealed that cytochalasin-induced binucleate cells assembled 
a single spindle at mitosis (86% segregate chromosomes and 
divide in a bipolar fashion; the remainder divide in a tripolar 
fashion; n = 121). All daughter cells were mononucleate after 
bipolar and tripolar mitoses. We never observed binucleate cells 
producing binucleate daughters. Centriole duplication in binu-
cleate cells was normal, and in mitosis, centriole distribution to 
daughter cells could be equal or unequal (Fig. S1, B and C).
Asynchronous cultures were treated with 0.5 µM cyto-
chalasin D for 10 h to induce a 26–38% incidence of binucleate 
cells. After drug removal, we cultured the mixture of diploid 
and binucleate cells for 100 h, at which time the culture was 
passaged and split. One culture was treated again with cytocha-
lasin, and the other was passaged seven times (50 doublings). 
This protocol was repeated four more times for a total of five 
rounds of cleavage failure (Fig. 1 A). For each round, we deter-
mined the incidence of centrosome amplification 100 h after 
cleavage failure and at passages 1, 3, and 7. The centrosome 
number per cell was determined by counting centrioles. Cells 
containing more than four centrin/-tubulin spots were scored 
as cases of centrosome amplification. Binucleate cells were not 
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To test whether this p53 response is caused by DNA dam-
age, we followed 36 binucleate cells and their progeny for 24 h, 
fixed them, and immunostained for nuclear phospho-H2AX 
foci, an indicator of DNA damage (Rogakou et al., 1998). Only 3 
of the 68 daughter cells still in view showed phospho-H2AX 
foci (see Uetake and Sluder, 2010 for validation of the method-
ology). Thus, DNA damage is not the primary reason for tetra-
ploid cells dropping out of the cell cycle.
We also examined whether doubled chromosome/centro-
some content sufficiently prolonged prometaphase to trigger 
a p53-dependent G1 arrest of the daughter cells (Uetake and 
We next followed 46 binucleate RPE1 cells for 24 h after 
cytochalasin-induced cleavage failure, fixed them, and double 
labeled for p53 and p21 expression. 10 of the 11 that arrested in 
first interphase as binucleate cells expressed p53 and/or p21 
(Fig. 2, A and C). For the 34 binucleates that divided, 45 of their 
daughters remained in the fields of view. 19 (42%) expressed 
p53 and/or p21, indicating that these were binucleate cell progeny 
that arrested after first mitosis (Fig. 2, B and C). Those not 
expressing p53 or p21 were presumably still cycling. Thus, 
cleavage failure can eventually lead to a p53 response and a 
p21-enforced cell cycle arrest.
Figure 1. Centrosome amplification and proliferation of untransformed cells after cleavage failure. (A) Centrosome amplification after repeated cleavage 
failure in RPE1 cell populations. Asynchronous cultures were treated with 0.5 µM cytochalasin D for 10 h (green bars) and split 100 h later. One culture 
was passaged seven times; the other was treated again with cytochalasin. This was repeated four more times. The percentages of binuclear cells after 
cytochalasin treatments are shown in blue. The percentages of centrosome amplification (more than four centrioles) are shown in bold with the number of 
cells counted shown above or below. (B) Proliferative capacity of binuclear cells and their progeny (yellow bars) and same-preparation control cells (green 
bars) after cytochalasin-induced cleavage failure. Bars show the percentage of cells that enter mitosis after completing the prior mitosis for each cell cycle; 
cells arresting in a previous cell cycle are not included. Percentages were calculated from lineages of multiple individual cells followed in one experiment. 
(C) Proliferative capacity of binuclear cells (yellow bars) and same-preparation control cells (green bars) after blebbistatin-induced cleavage failure. One 
experiment is shown on multiple cells.
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Though tetraploidy does not appear to greatly compromise prolif-
eration in the short term, the progressive arrest of initially tetraploid 
cells after they had divided one or more times suggests that other 
factors are in play to cause a cell cycle arrest. What these might be 
is an intriguing mystery because the genome and cytoplasmic vol-
umes, albeit doubled, are initially balanced and complete. Although 
doubled gene dosage might cause problems with the regulation of 
gene expression and growth control (Andalis et al., 2004; Upender 
et al., 2004), tetraploidy per se may not be the sole cause of the 
proliferation block. Proliferating tetraploid RPE1 cells with a nor-
mal centrosome complement can be selected through repeated 
FACS sorting (Ganem et al., 2009), and there are rare live births 
of tetraploid humans, albeit with lethal developmental defects 
Sluder, 2010). For tetraploid RPE1 cells, prometaphase was on 
average 40.9 min (range of 12–75 min; n = 56) versus 20.8 min 
(range of 12–54 min; n = 38) for the same preparation controls, 
which is consistent with Yang et al. (2008). However, even the long-
est prometaphase duration in tetraploid cells was not long enough 
to stop daughter cell proliferation (Uetake and Sluder, 2010).
Previous work revealed that untransformed cells do not 
possess a tetraploidy checkpoint because most binucleate cells 
progressed through S phase and first mitosis (Uetake and Sluder, 
2004). However, their progeny were not followed further. Our 
present longer term observations reveal that despite the lack of 
a classical checkpoint monitoring cleavage failure, the doubled 
condition is partially but poorly tolerated by untransformed cells. 
Figure 2. Expression of p53 and p21 in untransformed cells that stop cycling after cleavage failure. (A) Binuclear cell arrested after cleavage failure 
expressing p53 (red), p21 (green), and DNA (blue). (B) Daughters of a binuclear cell fixed 15 h after first tetraploid mitosis showing p53 (red) and 
p21 (green). (C) Percentages of cells expressing only p53, only p21, or both. The first column shows binucleates that arrested in first interphase, the second 
column shows daughters of binucleates, and the third column shows same-preparation control cells. Fluorescence micrographs are shown. Bar, 50 µm.
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doubled cell to eventually trigger a p53 response (Ganem and 
Pellman, 2007; Ganem et al., 2007; Uetake et al., 2007). Regardless 
of why cells drop out of the cell cycle, our observations reveal that 
cleavage failure, as a transient event, is not a major driver of an 
incidence of centrosome amplification in proliferating populations 
of untransformed cells.
Transformed cells
To determine whether cleavage failure can establish centrosome 
amplification in cell populations that continue proliferating, we 
repeated our experiments on three transformed cell lines with 
(Nakamura et al., 2003; Storchova and Pellman, 2004). Perhaps 
chromosome missegregations caused by multipolar divisions or 
merotelically attached chromosomes on bipolar spindles (Ganem 
et al., 2009; Silkworth et al., 2009) contribute to the cell cycle 
arrest. Single-chromosome gains or losses in diploid RPE1 cells 
lead to a rapid p53-dependent cell cycle arrest (Thompson and 
Compton, 2008, 2010), but it is not known whether or not such 
single-chromosome gains or losses can induce a cell cycle arrest on 
an initially tetraploid background. Perhaps increased gene dosage, 
chromosome missegregations, and cytoskeletal alterations caused 
by extra centrosomes act additively to sufficiently stress the 
Figure 3. Centrosome amplification and proliferation of HCT116 p53/ cells after cleavage failure. (A) Centrosome amplification in proliferative HCT116 
p53/ cell populations after repeated cleavage failure. The experimental protocol and display of the results are the same as those shown in Fig. 1 A. 
Large multinucleated cells are not scored because they do not proliferate. The percentages of binuclear cells after cytochalasin treatments are shown in 
blue. The percentages of centrosome amplification (more than four centrioles) are shown in bold with the number of cells counted shown above or below. 
(B) Proliferative capacity of binuclear cells (yellow bars) and same-preparation control cells (green bars). Orange portions of the bars indicate the percent-
ages of cells that spontaneously fail cleavage at mitosis. Such cells cycle but repeatedly fail cleavage and cease proliferating. One experiment is shown 
on multiple cells. (C, top) Binuclear cell (asterisks) exhibiting multiple rounds of cleavage failure, resulting in a large multinucleated cell. (bottom) Death of 
another large multinuclear cell. Times are in hours and minutes. Phase-contrast microscopy is shown. Bar, 50 µm.
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of 14 h (range of 11–17 h) with no slowing of the cell cycle later 
in the film runs (Fig. 3 B, green bars). All mitoses appeared nor-
mal with the exception of one cell that failed to cleave (Table S1). 
For 39 binucleate cells, 8–39% of their progeny failed cleav-
age at mitosis (Fig. 3 B, orange portions of yellow bars). 
Cells that spontaneously failed cleavage continued to cycle but 
repeatedly failed cleavage, yielding large multinucleated cells 
that eventually stopped cycling or died (Fig. 3 C).
For HeLa cells, we followed binucleate cells and their 
same-preparation control cells for up to 83 h when the cultures 
became confluent. Eight control cells and their progeny divided 
four times (Fig. 4 A, green bars) with a mean cell cycle duration 
of 22.3 h (range of 18–29 h). All 51 mitoses were bipolar, and 
defective p53 pathways. For HCT116 p53/ cells, we induced 
five rounds of 18–33% cleavage failure in asynchronous cultures 
using the same protocol used for RPE1 cells. Control populations 
showed a 1% incidence of centrosome amplification. Despite the 
five rounds of cleavage failure, we found that at 100 h, passage 1, 
and passage 7, the incidence of centrosome amplification was 
1% or less in proliferating mononucleated cells (Fig. 3 A). Large 
multinucleated cells resulting from repeated cleavage failure (see 
following paragraph) had many centrosomes but were not counted 
because they were not proliferative.
We followed individual binucleate cells and same-
 preparation controls for up to 125 h. 10 control cells and their 
progeny divided up to seven times with a mean cell cycle duration 
Figure 4. Centrosome amplification and proliferation of HeLa and CHO cells after cleavage failure. (A) Proliferative capacity of binuclear HeLa cells 
(yellow bars) and same preparation control cells (green bars). Black portions of bars indicate the percentage of the cells that die during or just after that 
mitosis. (B) Proliferative capacity of binuclear CHO cells (yellow bars) and same-preparation control cells (green bars). The darker portions of the yellow 
bars denote the percentage of cells that fail cleavage at each mitosis. (A and B) One experiment is shown on multiple cells. (C) Centrosome amplification 
after repeated cleavage failure in CHO cell populations. The experimental protocol and display of the results are the same as those shown in Fig. 1 A. The 
percentages of binuclear cells after cytochalasin treatments are shown in blue. The percentages of centrosome amplification (more than four centrioles) are 
shown in bold with the number of cells counted shown above or below.
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is to become stably established in proliferating populations of 
cancer cells, there must be an ongoing incidence of an event that 
increases centrosome numbers, be it cleavage failure or centriole 
reduplication/overduplication.
Materials and methods
Cell culture and live-cell imaging
hTERT-RPE1 cells (Takara Bio, Inc.) stably expressing low levels of human 
centrin1-GFP were cultured in 1:1 DME and Ham’s F12 media. Human 
primary foreskin fibroblasts (BJ strain, used at doublings 25–35) were ob-
tained from American Type Culture Collection and cultured in MEM media. 
HeLa cells (American Type Culture Collection) were grown in DME, and 
CHO-K1 cells (American Type Culture Collection) and CHO cells express-
ing centrin1-GFP (gift from A. Khodjakov, Wadsworth Center, New York 
State Department of Health, Albany, NY) were maintained in Ham’s F12 
medium. HCT116 p53/ cells (gift from W. Theurkauf, University of 
Massachusetts Medical School, Worcester, MA) were maintained in McCoy’s 
modified media. All media (Invitrogen) contained 12.5 mM Hepes, 10% 
FCS (Invitrogen), 100 U/ml penicillin G, and 100 µg/ml streptomycin 
(Invitrogen). 16–18 h before drug treatment, cells were seeded on 18 × 18– 
or 22 × 22–mm coverslips and pretreated with 1 ml of 20-µg/ml fibronectin 
solution (F1141; Sigma-Aldrich) for 1 h at 37°C on cleaned coverslips previ-
ously treated with poly-l-lysine (Sigma-Aldrich). Cytochalasin D (Sigma-
 Aldrich) was used at 0.5 µM by a dilution of 1,000× DMSO stock. Asyn-
chronous cultures were treated with 100 µM ()-blebbistatin (Sigma-Aldrich) 
for 50 min. Drug treatments were terminated by washing the coverslips with 
drug-free medium more than five times over a period of 30 min.
Shortly after drug removal, binucleate cells and their same-preparation 
controls were continuously filmed for 70–118 h. For continuous live-cell 
film runs, coverslips bearing cells were assembled into chambers 
containing 1:1 DME and Ham’s F12 media as previously described (Sluder 
et al., 2005). The medium was changed every second day. Individual bi-
nucleate cells were circled on the coverslip with a diamond scribe and then 
followed at 37°C with microscopes (Universal [Carl Zeiss]; BH2 [Olympus]; or 
DMEXE [Leica]) equipped with phase-contrast optics using 10× objectives/ 
0.3–0.32 NA. Image sequences were taken with cameras (Orca ER 
[Hamamatsu Photonics]; Retiga EX [Qimaging, Corp.]; or Retiga EXi Fast 
[Qimaging, Corp.]) in hoods enclosing the entire microscope. Images 
were acquired every 3 min with C-imaging software (Hamamatsu Photon-
ics) and were exported as QuickTime videos (90% of IndeoVideo 5.1 com-
pression mode or 100% of CinePak compression; Apple).
For GFP imaging of centrioles in living cells, single focal plane 
images or z stacks of three to eight images (40 ms each) were acquired 
every 4–12 h with a 100×/1.30 NA HCX PL Fluotar objective on a micro-
scope (DMR; Leica). Images were acquired with a camera (Orca ER) using 
SlideBook software (Intelligent Imaging Innovations). Z-stack images were 
compiled to form maximum intensity point projection images.
Immunocytochemistry
Cells were fixed with 20°C methanol and immunostained as previously 
described (Uetake et al., 2007). The antibodies used in this study were 
monoclonal anti–-tubulin antibody at 1:1,000 (Sigma-Aldrich) or 1:100 
(sc-51715; Santa Cruz Biotechnology, Inc.), p21 at 1:100 (7903; 
Abcam), p53 at 1:100 (sc-126; Santa Cruz Biotechnology, Inc.), phH2A.
X at 1:1,000 (07–164; Millipore), anti–mouse IgG Alexa Fluor 488 at 
1:1,000, or anti–rabbit IgG Alexa Fluor 594 at 1:1,000 (Invitrogen). 
Images were acquired with a 100×/1.30 NA oil HCX PL Fluotar or 
63×/1.32 NA oil HCX Plan Apochromat objective on a microscope (DMR). 
Images were acquired with a camera (Retiga EXi Fast) using SlideBook 
software. In preparing the figures, images were cropped and assembled 
using Photoshop software (Adobe). Only contrast and/or brightness adjust-
ments were made and performed uniformly across the entire images.
Online supplemental material
Fig. S1 shows hTERT-RPE1 cells expressing centrin1-GFP and its colocaliza-
tion with -tubulin as well as images from live-cell imaging of binucleate 
RPE1 cells and centriole duplication and distribution in these cells. Fig. S2 
displays the proliferative capacity of binucleate human primary fibroblasts 
after cytochalasin-induced cleavage failure. Table S1 summarizes mitotic 
outcomes for binucleate cells and same-preparation control cells for all cell 
lines used in this study. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.201101073/DC1.
one cell failed cleavage (Table S1). For 41 binucleate cells and 
their progeny, all mitoses showed evidence of spindle multi-
polarity; 58% of the cells cleaved in a multipolar fashion or in a 
bipolar but unequal fashion as judged by cell and nuclear size 
after mitosis. Their cell cycle duration averaged 24.2 h (range of 
17.5–33 h). After the first two tetraploid mitoses, a portion of the 
daughter cells died, and all died after the third mitosis (Fig. 4 A, 
black portion of yellow bars).
For CHO cells in 85-h film runs, five control cells divided 
in a bipolar fashion eight times with a mean cell cycle duration 
of 11.2 h (range of 9.5–16.5 h; n = 72; Fig. 4 B, green bars). The 
progeny of 21 same-preparation binucleate cells propagated for 
eight cycles with a mean cell cycle duration of 12 h (range of 
9.5–23 h; n = 160; Fig. 4 B, yellow bars). 90% of all mitoses 
(n = 150) were bipolar and equal in appearance, 4% were un-
equal, and 2–6% failed cleavage (Fig. 4 B, orange portions of 
the yellow bars; and Table S1).
In three experiments, we induced five rounds of cleavage 
failure using the protocol we used for RPE1 cells. Control popu-
lations showed a 3.0% incidence of centrosome amplification 
(n = 1,817). At 100 h, taking all cycles of cleavage failure together, 
the incidence of centrosome amplification ranged from 4.3 to 
9.3%. At passage 1, the incidence of centrosome amplification 
ranged from 3.5 to 6.3%, and at passage 7, it ranged from 2.9 to 
4.2% (Fig. 4 C). The incidence of centrosome amplification did 
not systematically increase with more rounds of induced cleav-
age failure or with increasing passage number.
Together, these observations reveal that the response of 
transformed cells to cleavage failure is cell line specific. For 
many transformed cell types, cleavage failure can be lethal, as 
we found for HeLa and Ganem et al. (2009) found for several 
other transformed lines. Perhaps these cell lines are particularly 
sensitive to unequal chromosome distribution induced by spindle 
multipolarity. For others, such as HCT116 p53/, cleavage fail-
ure predisposes cells to additional rounds of cleavage failure, 
resulting in huge cells that cease proliferating or die. It appears 
that this cell type does not have a sufficiently robust cleavage 
apparatus to divide larger than normal cells with high fidelity. 
Perhaps HCT116 p53/ cells after repeated cleavage failure are 
representative of cells from high grade human tumors that show 
extensive centrosome amplification (Lingle et al., 1998; Pihan 
et al., 1998; Sato et al., 1999), but whose proliferative capacity 
with many centrosomes is uncertain.
For CHO cells, repeated rounds of cleavage failure lead to 
a modest step up in the incidence of centrosome amplification 
at 100 h, and this incidence diminishes at later passages, though 
it sometimes remains slightly above the 3% control values. 
These observations suggest a source and sink situation for the 
incidence of proliferating cells with extra centrosomes (Nigg, 
2006). The source of centrosome amplification is an ongoing 
2–6% rate of cleavage failure for mitotic tetraploid cells. The 
sink may be that tetraploidy and/or extra centrosomes dimin-
ish the proliferative capacity of these cells under our culture 
conditions, as indicated by our finding that the incidence of 
centrosome amplification diminished at later passages and did 
not progressively increase with more cycles of cleavage failure. 
These observations suggest that if centrosome amplification 
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